vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

Madison Square Garden Sports Corp. is the larger business by last-quarter revenue ($403.4M vs $209.8M, roughly 1.9× MYRIAD GENETICS INC). On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs -0.4%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -3.1%).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

MSGS vs MYGN — Head-to-Head

Bigger by revenue
MSGS
MSGS
1.9× larger
MSGS
$403.4M
$209.8M
MYGN
Growing faster (revenue YoY)
MSGS
MSGS
+13.1% gap
MSGS
12.8%
-0.4%
MYGN
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-3.1%
MSGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSGS
MSGS
MYGN
MYGN
Revenue
$403.4M
$209.8M
Net Profit
$8.2M
Gross Margin
70.0%
Operating Margin
5.5%
-2.7%
Net Margin
2.0%
Revenue YoY
12.8%
-0.4%
Net Profit YoY
641.9%
EPS (diluted)
$0.34
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
MYGN
MYGN
Q4 25
$403.4M
$209.8M
Q3 25
$39.5M
$205.7M
Q2 25
$204.0M
$213.1M
Q1 25
$424.2M
$195.9M
Q4 24
$357.8M
$210.6M
Q3 24
$53.3M
$213.3M
Q2 24
$227.3M
$211.5M
Q1 24
$430.0M
$202.2M
Net Profit
MSGS
MSGS
MYGN
MYGN
Q4 25
$8.2M
Q3 25
$-8.8M
$-27.4M
Q2 25
$-1.8M
$-330.5M
Q1 25
$-14.2M
$-100.0K
Q4 24
$1.1M
Q3 24
$-7.5M
$-22.1M
Q2 24
$25.5M
$-36.7M
Q1 24
$37.9M
$-26.0M
Gross Margin
MSGS
MSGS
MYGN
MYGN
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Q1 24
68.1%
Operating Margin
MSGS
MSGS
MYGN
MYGN
Q4 25
5.5%
-2.7%
Q3 25
-69.5%
-11.3%
Q2 25
-11.1%
-154.5%
Q1 25
7.6%
-14.8%
Q4 24
3.7%
-18.6%
Q3 24
-15.5%
-9.4%
Q2 24
23.0%
-17.3%
Q1 24
18.5%
-13.8%
Net Margin
MSGS
MSGS
MYGN
MYGN
Q4 25
2.0%
Q3 25
-22.3%
-13.3%
Q2 25
-0.9%
-155.1%
Q1 25
-3.4%
-0.1%
Q4 24
0.3%
Q3 24
-14.1%
-10.4%
Q2 24
11.2%
-17.4%
Q1 24
8.8%
-12.9%
EPS (diluted)
MSGS
MSGS
MYGN
MYGN
Q4 25
$0.34
$-0.09
Q3 25
$-0.37
$-0.29
Q2 25
$-0.08
$-3.57
Q1 25
$-0.59
$0.00
Q4 24
$0.05
$-0.47
Q3 24
$-0.31
$-0.24
Q2 24
$1.07
$-0.41
Q1 24
$1.57
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$81.3M
$149.6M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$-282.1M
$368.0M
Total Assets
$1.5B
$706.6M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
MYGN
MYGN
Q4 25
$81.3M
$149.6M
Q3 25
$48.6M
$145.4M
Q2 25
$144.6M
$74.4M
Q1 25
$96.5M
$91.8M
Q4 24
$107.8M
$102.4M
Q3 24
$52.3M
$99.9M
Q2 24
$89.1M
$97.3M
Q1 24
$40.0M
$104.3M
Total Debt
MSGS
MSGS
MYGN
MYGN
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MSGS
MSGS
MYGN
MYGN
Q4 25
$-282.1M
$368.0M
Q3 25
$-294.2M
$372.8M
Q2 25
$-281.4M
$388.1M
Q1 25
$-283.4M
$704.9M
Q4 24
$-273.1M
$701.1M
Q3 24
$-277.5M
$731.7M
Q2 24
$-266.3M
$740.5M
Q1 24
$-294.0M
$760.0M
Total Assets
MSGS
MSGS
MYGN
MYGN
Q4 25
$1.5B
$706.6M
Q3 25
$1.5B
$728.1M
Q2 25
$1.5B
$677.3M
Q1 25
$1.5B
$1.0B
Q4 24
$1.4B
$1.0B
Q3 24
$1.4B
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.4B
$1.1B
Debt / Equity
MSGS
MSGS
MYGN
MYGN
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
MYGN
MYGN
Operating Cash FlowLast quarter
$32.4M
$10.6M
Free Cash FlowOCF − Capex
$31.6M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
3.94×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
MYGN
MYGN
Q4 25
$32.4M
$10.6M
Q3 25
$-85.0M
$21.1M
Q2 25
$49.7M
$-13.6M
Q1 25
$6.3M
$-16.3M
Q4 24
$61.8M
$6.6M
Q3 24
$-26.2M
$700.0K
Q2 24
$108.4M
$2.6M
Q1 24
$4.0M
$-18.6M
Free Cash Flow
MSGS
MSGS
MYGN
MYGN
Q4 25
$31.6M
Q3 25
$-85.3M
Q2 25
$49.4M
Q1 25
$3.9M
Q4 24
$61.2M
Q3 24
$-26.5M
Q2 24
$108.0M
Q1 24
$3.9M
FCF Margin
MSGS
MSGS
MYGN
MYGN
Q4 25
7.8%
Q3 25
-216.3%
Q2 25
24.2%
Q1 25
0.9%
Q4 24
17.1%
Q3 24
-49.7%
Q2 24
47.5%
Q1 24
0.9%
Capex Intensity
MSGS
MSGS
MYGN
MYGN
Q4 25
0.2%
Q3 25
0.9%
Q2 25
0.2%
Q1 25
0.6%
Q4 24
0.1%
Q3 24
0.7%
Q2 24
0.2%
Q1 24
0.0%
Cash Conversion
MSGS
MSGS
MYGN
MYGN
Q4 25
3.94×
Q3 25
Q2 25
Q1 25
Q4 24
55.61×
Q3 24
Q2 24
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons